Avalon Pharma has established itself as a leading innovator in the pharmaceutical and healthcare industry with a diverse portfolio of over 70 brands.
These products span a wide range of therapeutic categories, ensuring Avalon’s ability to address a broad spectrum of medical needs.
Key Therapeutic Categories:
Respiratory
Cardiovascular
Alimentary & Anti-infectives
Musculoskeletal
CNS (Central Nervous System)
Genitourinary Systems
Commercial
As Avalon Pharma continues to solidify its position as a leading pharmaceutical company, the Commercial pillar plays a critical role in enhancing sales performance, market access, and operational efficiency.
1. Strengthening Revenue Growth & Market Positioning
In 2024, Avalon Pharma achieved total revenue of 394 million, marking a 16.4% year-on-year increase.
Private Market Contribution
268 million
68% of total sales
Private Market Contribution
75 million
19% of total sales
Export Sales Expansion
50 million
13% of total sales
2. Optimising Profitability & Gross Margin Performance
In 2024, the company reported a gross profit of 243 million, with an overall gross profit margin (GP%) of 61.8%.
Private Market GP%
71.3%
Institutional Market GP%
36.7%
10.06 ppt improvement
Export GP%
48.7%
3. Expansion into New Markets & Growth Opportunities
The Commercial strategy has enabled Avalon to accelerate market expansion across key territories.
Domestic Growth Initiatives
Increased penetration in Wasfaty tenders, and hospital supply agreements.
International Expansion
UAE & Kuwait: Strong regulatory approvals and B2B collaborations.
New Market Entry Strategy: Focus on Egypt, Indonesia, Malaysia, and Morocco
4. Enhancing Commercial Execution & Operational Efficiency
Avalon Pharma is committed to maximising sales effectiveness and leveraging digital transformation to drive operational efficiencies.
Sales Force Optimisation
Implementation of structured territory management, enabling target market coverage and improved conversion rates.
Digital & E-Commerce Growth
Expansion of direct-to-consumer (DTC) strategies, including
e-commerce platforms and Project Matrix (influencer-led brand engagement).
Demand Forecasting
Enhanced market intelligence capabilities to optimise inventory planning and mitigate supply chain risks.
Manufacturing
Avalon Pharma’s manufacturing capabilities are a cornerstone of its commitment to delivering high-quality pharmaceutical products.
Comprehensive Manufacturing Capabilities
Avalon Pharma excels in producing over 300 SKUs, supported by a robust pipeline of more than 40 molecules under development.
Commitment to Sustainability and Compliance
Avalon Pharma upholds strict environmental and regulatory standards, reinforcing its dedication to responsible manufacturing:
Specialised Manufacturing Facilities
Avalon Pharma operates a network of cutting-edge facilities, each tailored to specific healthcare needs:
Private Label Expertise
As a trusted private label manufacturer, Avalon Pharma collaborates with customers to deliver high-quality products
Advancing Through Research and Development
Innovation drives Avalon’s manufacturing success. Its R&D centre fosters a culture of exploration, supporting product development through analytical expertise and cutting-edge technologies.
+300 SKUS
Avalon Pharma excels in producing
+40
Molecules under development
+270
Tablets and capsules annually
Operational Review
Avalon Pharma’s manufacturing operations in 2024 were marked by record-breaking performance, underpinned by robust processes and a commitment to excellence.
24/7
production across 80% of its manufacturing lines
ISO 14001
certification
High-demand products such as injectables and ophthalmological treatments, with commercialization expected by
2027
Business Development
Vision for Growth
Avalon’s business development efforts align closely with its ACE strategy (Accelerate, Catalyse, Expand). These initiatives prioritise
Expanding market reach through strategic alliances and licensing agreements.
Enhancing manufacturing capabilities to meet global healthcare demands
Strengthening Avalon’s leadership position in key therapeutic categories
Operational Review
Avalon’s Business Development efforts in 2024 were pivotal in driving the Company’s strategic roadmap and aligning with its ambitious goals under the ACE framework—Accelerate, Catalyse, and Expand. With a focus on innovation, strategic alliances, and market expansion, the department significantly contributed to Avalon’s growth trajectory.
Strategic Alliances And In-Licensing
Avalon enhanced its partnerships with prominent retailers like Nahdi and Al-Dawaa
Market Expansion
Significant growth was achieved in export markets, with successful relaunches in Kuwait and the UAE
Innovation-Driven Pipeline
Avalon’s R&D efforts resulted in robust product innovation, supported by strategic technology transfer agreements
Sustainability
Using Renewable Energy
Safe Discarding
Reduce Power Consumption
Reduce Water Consumption
Reduce Generated Waste
Avalon Site go Green Project
Sustainability – A Stepping Stone to ESG
In line with Saudi Arabia’s Vision 2030, Avalon is fully committed to a sustainable future for all.
Encouraging Sustainable Practices
Avalon is always looking to digitise its activities where possible, significantly reducing the more conventional paper-based way of working.
The most substantial environmental impact, however, is seen in manufacturing, where Avalon is licensed and registered with the Saudi Environmental Authority.
2024 also marked a significant step for the Company, where it moved away from the older, diesel- powered generators to power its factories, instead sourcing electricity from the Saudi Electricity Company.
Expanding market reach through strategic alliances and licensing agreements.
Enhancing manufacturing capabilities to meet global healthcare demands
Strengthening Avalon’s leadership position in key therapeutic categories
Woman Empowerment
At Avalon Pharma, women empowerment is a key focus, ensuring that female employees have the resources, opportunities, and support to thrive in the workplace.
Leadership Development
Avalon Pharma offers leadership training and development programs specifically designed for women.
Mentorship Opportunities
The company provides mentorship programs, pairing women with senior leaders to guide them
Work-life Balance Initiatives
Avalon Pharma is committed to supporting its employees’ well-being by offering flexible work schedules, remote working options, and family-friendly policies
Equal Pay and Advancement
Avalon Pharma ensures equal pay for equal work, promoting fairness and transparency in compensation and career progression.
Employee Programs
In 2024, several initiatives were launched to foster an inclusive, dynamic, and positive work environment.
Health And Safety
The Company ensure that every location, from factories to offices, has at least 1 health and safety specialist,
CSR Initiatives
Avalon’s CSR initiatives focused on societal and environmental impact, encompassing health campaigns, community support, and sustainability programs.